Boston Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1M Sell
379,999
-240,361
-39% -$16.4M 0.03% 339
2025
Q4
$36.7M Buy
620,360
+363,584
+142% +$19.7M 0.04% 296
2025
Q3
$14.2M Buy
+256,776
New +$13.4M 0.01% 402
2023
Q4
Sell
-420,421
Closed -$19.5M 753
2023
Q3
$19.5M Sell
420,421
-92,704
-18% -$5.06M 0.03% 313
2023
Q2
$29.8M Sell
513,125
-19,077
-4% -$1.14M 0.04% 274
2023
Q1
$38.1M Buy
532,202
+142,136
+36% +$11.3M 0.05% 244
2022
Q4
$28.3M Buy
390,066
+5,731
+1% +$404K 0.04% 264
2022
Q3
$23.6M Sell
384,335
-10,214
-3% -$685K 0.03% 278
2022
Q2
$25.1M Buy
394,549
+7,911
+2% +$516K 0.04% 289
2022
Q1
$24.6M Sell
386,638
-1,066,391
-73% -$71.3M 0.03% 304
2021
Q4
$104M Sell
1,453,029
-591,602
-29% -$45M 0.13% 199
2021
Q3
$146M Sell
2,044,631
-283,420
-12% -$22.4M 0.19% 174
2021
Q2
$189M Buy
2,328,051
+39,191
+2% +$3.15M 0.24% 142
2021
Q1
$173M Buy
2,288,860
+151,679
+7% +$11M 0.23% 144
2020
Q4
$162M Sell
2,137,181
-19,798
-0.9% -$1.29M 0.25% 130
2020
Q3
$107M Sell
2,156,979
-46,900
-2% -$2.65M 0.19% 158
2020
Q2
$116M Buy
2,203,879
+2,081,795
+1,705% +$98.8M 0.21% 144
2020
Q1
$4.29M Buy
+122,084
New +$7.13M 0.01% 373

Other funds holding NGVT

Boston Partners's NGVT Position: Q1 2026 in Review

Boston Partners reduced its Ingevity (NGVT) stake by 39% in Q1 2026, selling an estimated $16.4M and leaving 379,999 shares worth $27.1M. The position accounts for 0.03% of the portfolio, ranked #339.

Boston Partners first reported a position in NGVT in Q1 2020 and has held it in 18 quarters since. The position peaked at $189M in Q2 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Boston Partners held 379,999 shares of Ingevity worth $27.1M as of Q1 2026.
  • Boston Partners sold 240,361 Ingevity shares in Q1 2026, an estimated $16.4M.
  • Ingevity made up 0.03% of Boston Partners's portfolio in Q1 2026, its #339 holding.
  • Boston Partners first reported a position in Ingevity in Q1 2020 and has held it in 18 quarters since.
  • Boston Partners's Ingevity position peaked at $189M in Q2 2021.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.